ebs

Sector Update: Healthcare

Healthcare stocks were mostly higher today with the NYSE Healthcare Sector Index rising 0.7% and shares of healthcare companies in the S&P 500 climbing 1.1% as a group.

In company news, shares of Emergent BioSolutions Inc. ( EBS ) were sharply lower late Monday after analysts at TheStreet.com reduced their stock recommendation to Hold from Buy, citing deteriorating profits, disappointing return on equity and weak operating cash flow.

EBS shares were down 5.4% at $21.51 each, earlier sliding to a session low of $21.36 a share. The stock has a 52-week range of $13.89 to $28.48 a share, rising just under 50% in value over the past 12 months.

In other sector news,

(+) ISR, State regulators approve company plans to produce liquid Cesium-131 at its facility in Richland, Wash. The FDA previous approved the medical isotope - know commercially as Cesitrex - to treat brain tumors using GliaSite balloon catheters.

(-) INO, Q1 net loss widens to $10 mln, or $0.05 per share, from $6.6 mln loss last year and trailing analyst expectations for a $0.04 per share net loss. Revenue rises 60% year over year to $2.4 mln, topping Street view by nearly $1 mln.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.